The role of depletion of dimethyl sulfoxide before autografting: on hematologic recovery, side effects, and toxicity
Open Access
- 29 February 2004
- journal article
- clinical trial
- Published by Elsevier in Transplantation and Cellular Therapy
- Vol. 10 (2) , 135-141
- https://doi.org/10.1016/j.bbmt.2003.09.016
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- High-dose chemotherapy followed by autologous blood cell transplantation: a safe and effective outpatient approachBone Marrow Transplantation, 1997
- Reversible encephalopathy after cryopreserved peripheral blood stem cell infusionAmerican Journal of Hematology, 1994
- Differential sensitivity to cryopreservation of clonogenic progenitor cells and stromal precursors from leukemic and normal bone marrowThe International Journal of Cell Cloning, 1994
- Hematopoietic Stem Cell Cryopreservation: A Review of Current TechniquesJournal of Hematotherapy, 1992
- Adverse reactions in patients transfused with cryopreserved marrowTransfusion, 1991
- Clinical toxicity of cryopreserved bone marrow graft infusionBlood, 1990
- Autologous transplantation of blood-derived hemopoietic stem cells after myeloablative therapy in a patient with Burkitt's lymphomaBlood, 1986
- Factors influencing myeloid stem cell (CFU-C) survival after cryopreservation of human marrow and chronic granulocytic leukemia cellsCryobiology, 1982
- Collection, Cryopreservation and Subsequent Viability of Haemopoietic Stem Cells Intended for Treatment of Chronic Granulocytic Leukaemia in Blast‐Cell TransformationBritish Journal of Haematology, 1978
- The Pharmacology of Dimethyl SulfoxideAnnual Review of Pharmacology, 1972